These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 16161208)

  • 1. Patent. Battle lines are drawn over generic AIDS drug.
    AIDS Policy Law; 2005 Aug; 20(16):6. PubMed ID: 16161208
    [No Abstract]   [Full Text] [Related]  

  • 2. Patent infringement. Generic HIV drugmaker's patent claim is time-barred.
    AIDS Policy Law; 2003 Aug; 18(16):6. PubMed ID: 14626916
    [No Abstract]   [Full Text] [Related]  

  • 3. Tripping over patents: AIDS, access to treatment and the manufacturing of scarcity.
    Berger JM
    Conn J Int Law; 2002; 17(2):157-248. PubMed ID: 12688292
    [No Abstract]   [Full Text] [Related]  

  • 4. . . . and Brazilian AIDS programme threatened by US trade action.
    Int J Epidemiol; 2001 Apr; 30(2):413. PubMed ID: 11369751
    [No Abstract]   [Full Text] [Related]  

  • 5. Amendments to the Canadian Patent Act to address drug access: is help on the way?
    Penner MD; Narayanan P
    Food Drug Law J; 2005; 60(3):459-70. PubMed ID: 16304751
    [No Abstract]   [Full Text] [Related]  

  • 6. TRIPS: generic irony.
    Howarth GR
    Br J Gen Pract; 2002 Jan; 52(474):57. PubMed ID: 11791819
    [No Abstract]   [Full Text] [Related]  

  • 7. Generics battle brand names over mortality of drug patents.
    Betz R
    J Healthc Resour Manag; 1995 Jul; 13(7):35-7. PubMed ID: 10144008
    [No Abstract]   [Full Text] [Related]  

  • 8. Action alert: drug-patent bill could cost patients $3 billion+; hearing July 1.
    AIDS Treat News; 1999 Jun; (No 321):8. PubMed ID: 11366716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AIDS drugs. Brazil, Thailand override big pharma patents.
    Cohen J
    Science; 2007 May; 316(5826):816. PubMed ID: 17495145
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug patent protection: how long is long enough?
    Sibbald B
    CMAJ; 2001 May; 164(9):1331. PubMed ID: 11341146
    [No Abstract]   [Full Text] [Related]  

  • 11. Brand-name drug manufacturers risk antitrust violations by slowing generic production through patent layering.
    Paine CS
    Seton Hall Law Rev; 2003; 33(2):479-510. PubMed ID: 12715807
    [No Abstract]   [Full Text] [Related]  

  • 12. European Commission targets drug firms over illegal patent protection.
    Watson R
    BMJ; 2010 Jan; 340():c268. PubMed ID: 20080819
    [No Abstract]   [Full Text] [Related]  

  • 13. The Drug Price Competition and Patent Term Restoration Act of 1984: fine-tuning the balance between the interests of pioneer and generic drug manufacturers.
    Soehnge H
    Food Drug Law J; 2003; 58(1):51-80. PubMed ID: 12739584
    [No Abstract]   [Full Text] [Related]  

  • 14. Old drugs, new uses: solving a Hatch-Waxman patent predicament.
    McPhie DC
    Food Drug Law J; 2004; 59(1):155-68. PubMed ID: 15190929
    [No Abstract]   [Full Text] [Related]  

  • 15. The emerging effects of the Drug Price Competition and Patent Term Restoration Act of 1984.
    Lewis RA
    J Contemp Health Law Policy; 1992; 8():361-78. PubMed ID: 10118987
    [No Abstract]   [Full Text] [Related]  

  • 16. Intellectual property. Balancing innovation and access: patent challenges tip the scales.
    Higgins MJ; Graham SJ
    Science; 2009 Oct; 326(5951):370-1. PubMed ID: 19833944
    [No Abstract]   [Full Text] [Related]  

  • 17. Legal challenge to India's patent laws threatens access to generic drugs, says charity.
    Moszynski P
    BMJ; 2011 Sep; 343():d5753. PubMed ID: 21908529
    [No Abstract]   [Full Text] [Related]  

  • 18. [The patent legislation in India fails the HIV/AIDS work].
    Holen Ø
    Tidsskr Nor Laegeforen; 2005 Oct; 125(19):2666-7. PubMed ID: 16215618
    [No Abstract]   [Full Text] [Related]  

  • 19. Brazil and USA at loggerheads over production of generic antiretrovirals.
    Ahmad K
    Lancet; 2001 Feb; 357(9254):453. PubMed ID: 11273079
    [No Abstract]   [Full Text] [Related]  

  • 20. Health policy or intellectual property policy? The fight over Bill C-91. Canadian Healthcare Association.
    Int J Health Care Qual Assur Inc Leadersh Health Serv; 1997; 10(2-3):vii-x. PubMed ID: 10169229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.